(Q38976344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

meta-analysis

0 references

title

Emollients and moisturisers for eczema (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Zbys Fedorowicz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Bernd Wm Arents

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Robin Christensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Adriana Lavrijsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

6 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

1 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

page(s)

CD012119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults

1 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Comparison of Moisturizing Creams for the Prevention of Atopic Dermatitis Relapse: A Randomized Double-blind Controlled Multicentre Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Long-term emollient therapy improves xerosis in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

An evaluation of prescription device moisturizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A randomized, single-blind comparison of the efficacy, tolerability and cosmetic acceptance of Propyless or Fenuril treatment of patients with dry skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Electrical conductance: a controversial parameter in the evaluation of emollients in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Efficacy and tolerance assessment of a new type of dermocosmetic in infants and children with moderate atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Do urea and sodium chloride together increase the efficacy of moisturisers for atopic dermatitis Skin? A comparative, double-blind and randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Affordable moisturisers are effective in atopic eczema: A randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Effect of emollients containing vegetable-derived lactobacillus in the treatment of atopic dermatitis symptoms: split-body clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split-body randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden--with model applications for Denmark, Norway and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Bath additives for the treatment of childhood eczema (BATHE): protocol for multicentre parallel group randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Qualitative vs. quantitative atopic dermatitis criteria - in historical and present perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Oral H1 antihistamines as monotherapy for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Management of difficult-to-treat atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Topical pimecrolimus for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Oral evening primrose oil and borage oil for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Dietary exclusions for established atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Dietary supplements for established atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Atopic eczema or atopiform dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Probiotics for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Specific allergen immunotherapy for the treatment of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

FTIR studies show lipophilic moisturizers to interact with stratum corneum lipids, rendering the more densely packed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Topical corticosteroid phobia in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Olive Oil, Sunflower Oil or no Oil for Baby Dry Skin or Massage: A Pilot, Assessor-blinded, Randomized Controlled Trial (the Oil in Baby SkincaRE [OBSeRvE] Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Epidermal barrier dysfunction in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Topical tacrolimus for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A functional mechanistic study of the effect of emollients on the structure and function of the skin barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Atopic dermatitis and the atopic march revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Lipid abnormalities and lipid-based repair strategies in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Psychological and educational interventions for atopic eczema in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

How atopic is atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The role of atopic sensitization in flexural eczema: Findings from the International Study of Asthma and Allergies in Childhood Phase Two

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

New insights into the epidemiology of childhood atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Leukotriene receptor antagonists for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Chinese herbal medicine for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Early life risk factors for atopic dermatitis in Ethiopian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Skin absorption through atopic dermatitis skin: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Allergic characteristics of urban schoolchildren with atopic eczema in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Point and period prevalences of eczema in rural and urban schoolchildren in Ghana, Gabon and Rwanda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Assessment of atopic eczema: clinical scoring and noninvasive measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Complementary and alternative medicine treatments for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Morbidity and cost of atopic eczema in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Influence of sunflower seed oil on the skin barrier function of preterm infants: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Japanese Guideline for Atopic Dermatitis 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Effects of systemic immunosuppressive therapies for moderate-to-severe eczema in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

What is meant by a "flare" in atopic dermatitis? A systematic review and proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Environmental factors, parental atopy and atopic eczema in primary-school children: a cross-sectional study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Atopic dermatitis: new insights and opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The Infants' Dermatitis Quality of Life Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Effect of moisturizers on epidermal barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Different strategies for using topical corticosteroids for established eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Use of emollients in dry-skin conditions: consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Atopic eczema: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

House dust mite reduction and avoidance measures for treating eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Patient reported outcome measures in practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Atopic dermatitis: global epidemiology and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Prevalence of community-acquired methicillin-resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Molecular basis for stratum corneum maturation and moisturization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Interpretation of random effects meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Guidelines for management of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The connection between in vitro water uptake and in vivo skin moisturization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Parents' and carers' views about emollients for childhood eczema: qualitative interview study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

What are the best outcome measurements for atopic eczema? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

EEMCO guidance for the assessment of dry skin (xerosis) and ichthyosis: clinical scoring systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Atopic dermatitis: an evidence-based treatment update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A pilot study of emollient therapy for the primary prevention of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Validation of treatment escalation as a definition of atopic eczema flares

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The important role of stratum corneum lipids for the cutaneous barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Clinical practice. Atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

How epidemiology has challenged 3 prevailing concepts about atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Is eczema really on the increase worldwide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Emollients and moisturisers for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Loss-of-Function Mutations in the Filaggrin Gene Lead to Reduced Level of Natural Moisturizing Factor in the Stratum Corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119.PUB2

Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle

21 January 2018

1 reference

12 December 2020

Urea creams in the treatment of dry skin and hand dermatitis

1 reference

12 December 2020

Systematic review of treatments for atopic eczema.

1 reference

12 December 2020

Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis

1 reference

12 December 2020

Moisturizer technology versus clinical performance

1 reference

12 December 2020

Effects of petrolatum on stratum corneum structure and function

1 reference

12 December 2020

A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.

1 reference

12 December 2020

Biophysical assessment of atopic dermatitis skin and effects of a moisturizer

1 reference

12 December 2020

A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.

1 reference

12 December 2020

Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis

1 reference

12 December 2020

The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study

1 reference

12 December 2020

Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study

1 reference

12 December 2020

A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients

1 reference

12 December 2020

The effect of ceramide-containing skin care products on eczema resolution duration

1 reference

12 December 2020

Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis

1 reference

12 December 2020

Hydrophilic and lipophilic moisturizers have similar penetration profiles but different effects on SC water distribution in vivo

1 reference

12 December 2020

Lack of efficacy of topical furfuryl palmitate in pediatric atopic dermatitis: a randomized double-blind study.

1 reference

12 December 2020

Canadian practical guide for the treatment and management of atopic dermatitis

1 reference

12 December 2020

Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis

1 reference

12 December 2020

Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review

1 reference

12 December 2020

Efficacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczema in children: a multicentre, randomized vehicle-controlled trial

1 reference

12 December 2020

Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study

1 reference

12 December 2020

Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial

1 reference

12 December 2020

An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.

1 reference

12 December 2020

The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis

1 reference

12 December 2020

Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.

1 reference

12 December 2020

A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.

1 reference

12 December 2020

A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults

1 reference

12 December 2020

A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis

1 reference

12 December 2020

Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor

1 reference

12 December 2020

Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care

1 reference

12 December 2020

Management of patients with atopic dermatitis: the role of emollient therapy

1 reference

12 December 2020

Managing childhood eczema: qualitative study exploring carers' experiences of barriers and facilitators to treatment adherence

1 reference

12 December 2020

Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis

1 reference

12 December 2020

Three randomised phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis

1 reference

12 December 2020

Steroid-sparing properties of emollients in dermatology

1 reference

12 December 2020

Persistence of mild to moderate atopic dermatitis

1 reference

12 December 2020

The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

A randomized, investigator-blinded efficacy assessment study of stand-alone emollient use in mild to moderately severe atopic dermatitis flares

1 reference

12 December 2020

Can early skin care normalise dry skin and possibly prevent atopic eczema? A pilot study in young infants

1 reference

12 December 2020

Comparative trial of moisturizer containing spent grain wax, Butyrospermum parkii extract, Argania spinosa kernel oil vs. 1% hydrocortisone cream in the treatment of childhood atopic dermatitis.

1 reference

12 December 2020

Effect of skin barrier emulsion cream vs a conventional moisturizer on transepidermal water loss and corneometry in atopic dermatitis: a pilot study

1 reference

12 December 2020

Scoring atopic dermatitis: the simpler the better?

1 reference

12 December 2020

Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis.

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch

1 reference

12 December 2020

Grading of the severity of atopic dermatitis.

1 reference

12 December 2020

Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population

1 reference

12 December 2020

The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use.

1 reference

12 December 2020

Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party

1 reference

12 December 2020

Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children

1 reference

12 December 2020

The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

12 December 2020

10.1002/14651858.CD012119.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28166390%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

PubMed publication ID

28166390

1 reference